January 07, 2026-- NeuraLight, the leader in developing precision biomarkers for neurology, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with standard ...
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...
The market is expanding rapidly due to increasing neurological disorders, demand for early diagnosis & personalized treatment ...
Prolonged exposure to poor air quality, especially high PM2.5 levels, can cause lasting neurological damage, particularly in developing brains. Experts warn that exposure during pregnancy and early ...
Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for autoimmune, ...
Researchers in Japan built a miniature human brain circuit using fused stem-cell–derived organoids, allowing them to watch ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated ...
BRC Therapeutics (BRC), a pharmaceutical company developing proprietary therapeutics for neurological and inflammatory diseases, tod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback